Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parag Kale

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Cardiology|November 25, 2017
Validation of Peripherally Inserted Central Catheter-Derived Fick Cardiac Outputs in Patients with Heart FailureKristen M Tecson, Anupama Vasudevan, Amarinder Bindra, et al.
Proceedings (Baylor University. Medical Center)|May 6, 2021
Trends in post-heart transplant biopsies for graft rejection versus nonrejectionAayla K Jamil, Aasim Afzal, Tariq Nisar, et al.
The American Journal of Cardiology|April 2, 2022
Trends in Hospital Admissions for Systolic and Diastolic Heart Failure in the United States Between 2004 and 2017Aasim Afzal, Johanna van Zyl, Tariq Nisar, et al.
Neurology and Therapy|July 31, 2023
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with PolyneuropathyLaura Obici, Senda Ajroud-Driss, Kon-Ping Lin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 28, 2018
Donor predicted heart mass as predictor of primary graft dysfunctionTimothy A Gong, Susan M Joseph, Brian Lima, et al.
Transplant Immunology|February 7, 2024
Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantationAmit Alam, Johanna S van Zyl, Raksha Patel, et al.
European Journal of Heart Failure|February 7, 2024
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathyPablo Garcia-Pavia, Martha Grogan, Parag Kale, et al.
Clinical Transplantation|September 30, 2017
Utilization of high donor sequence number grafts in cardiac transplantationJohn J Squiers, J Michael DiMaio, Giovanna Saracino, et al.
Clinical Transplantation|September 16, 2021
De novo tacrolimus extended-release tablets (LCPT) versus twice-daily tacrolimus in adult heart transplantation: Results of a single-center non-inferiority matched control trialJohanna S van Zyl, Teena Sam, Donna M Clark, et al.
The New England Journal of Medicine|October 27, 2023
Patisiran Treatment in Patients with Transthyretin Cardiac AmyloidosisMathew S Maurer, Parag Kale, Marianna Fontana, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Cardiology|November 25, 2017
Validation of Peripherally Inserted Central Catheter-Derived Fick Cardiac Outputs in Patients with Heart FailureKristen M Tecson, Anupama Vasudevan, Amarinder Bindra, et al.
Proceedings (Baylor University. Medical Center)|May 6, 2021
Trends in post-heart transplant biopsies for graft rejection versus nonrejectionAayla K Jamil, Aasim Afzal, Tariq Nisar, et al.
The American Journal of Cardiology|April 2, 2022
Trends in Hospital Admissions for Systolic and Diastolic Heart Failure in the United States Between 2004 and 2017Aasim Afzal, Johanna van Zyl, Tariq Nisar, et al.
Neurology and Therapy|July 31, 2023
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with PolyneuropathyLaura Obici, Senda Ajroud-Driss, Kon-Ping Lin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 28, 2018
Donor predicted heart mass as predictor of primary graft dysfunctionTimothy A Gong, Susan M Joseph, Brian Lima, et al.
Transplant Immunology|February 7, 2024
Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantationAmit Alam, Johanna S van Zyl, Raksha Patel, et al.
European Journal of Heart Failure|February 7, 2024
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathyPablo Garcia-Pavia, Martha Grogan, Parag Kale, et al.
Clinical Transplantation|September 30, 2017
Utilization of high donor sequence number grafts in cardiac transplantationJohn J Squiers, J Michael DiMaio, Giovanna Saracino, et al.
Clinical Transplantation|September 16, 2021
De novo tacrolimus extended-release tablets (LCPT) versus twice-daily tacrolimus in adult heart transplantation: Results of a single-center non-inferiority matched control trialJohanna S van Zyl, Teena Sam, Donna M Clark, et al.
The New England Journal of Medicine|October 27, 2023
Patisiran Treatment in Patients with Transthyretin Cardiac AmyloidosisMathew S Maurer, Parag Kale, Marianna Fontana, et al.
Pageof 2